Rip cord

1 December 2004 By Rob Cox

Merck put the issue on the front burner by instituting up to three years’ severance for 230 managers in the event of a merger. It said the move was not related to the Vioxx recall. Yet this was about the only justification if a weak one for the plan.

This content is for Subscribers only

To access full content you must be a subscriber. Please use the following link to request a trial.


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)